TechWeek and Healthtech Week have come and gone, finishing off a busy round of events topped off with several awards for healthtech companies.
At the same time, strong annual result announcements from the likes of Fisher & Paykel Healthcare and AFT Pharmaceuticals have contributed to an estimated $2.85B in revenues for the NZ healthtech sector in the 2020-21 financial year - massive growth in the past 2 years and part of the discussion in our recent sector update.
In this edition of the HealthTech Activator (HTA) Monthly Wrap, we share highlights from Healthtech Week’s Innovation Day, insights from healthtech multinationals, and other news from the healthtech community.
Innovation Day (22 June), supported by Callaghan Innovation and the HTA, included a busy day of presentations from healthtech leaders across the public and private sphere, with a highlight being a livestream with Sarah Chang, Worldwide Director for Sustainability at Johnson & Johnson.
Greg Shanahan, founder of TIN, also announced a planned 2022 update to the TIN HealthTech Insights Report and provided a peak into recent sector growth. Opportunity and collaboration were a prevailing theme, built on in talks by Ju Zhang of Formus Labs, MTANZ’s Faye Sumner, Diana Siew of the Auckland Bioengineering Institute, and the HTA’s Andrew Clews.
Throughout the day, a group of healthtech companies participated in a showcase that was open to all - a melting pot of innovation and networking - with the day culminating in a festive Gala Dinner and Awards night.
Congratulations to the following companies and researcher for their awards:
Tim McCready, BioPacific Partners
Healthtech is changing with the rapid rise of digital innovation, while multinational corporations continue to look for smaller companies to bolster their innovation pipelines. As tech giants make moves to establish themselves in the healthtech market, Tim McCready speaks with healthtech multinationals about changes in the industry and why they are interested in NZ innovation.